Cargando…

Genetic Factors Influencing Drug-Induced Liver Injury: Do They Have a Role in Prevention and Diagnosis?

PURPOSE OF REVIEW: The pathogenesis of DILI is currently unknown; however, research has shown strong genetic associations with some DILIs. This paper describes the variant alleles uncovered by GWAS and discusses their potential role as susceptibility biomarkers. RECENT FINDINGS: An association with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clare, Kathleen E., Miller, Michael H., Dillon, John F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Drug-Induced Liver Injury (F Bessone and R Andrade, Section Editors)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556130/ https://www.ncbi.nlm.nih.gov/pubmed/28856081 http://dx.doi.org/10.1007/s11901-017-0363-9

Ejemplares similares

Editor Profiles: Guest Editors of Special Column on Drug- and Chemical-Induced Liver Injury
Publicado: (2021)

Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors
por: Woodhead, Jeffrey L., et al.
Publicado: (2017)

Care of the Hepatology Patient in the COVID-19 Era
por: Driggers, Kathryn E., et al.
Publicado: (2022)

Pembrolizumab-related renal toxicities: diagnosis first, treatment later
por: Sprangers, Ben
Publicado: (2018)

Azathioprine hypersensitivity syndrome in anti-myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Greite, Robert, et al.
Publicado: (2018)

Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension
por: Hanna, Ramy M, et al.
Publicado: (2018)

Renal toxicities associated with pembrolizumab
por: Izzedine, Hassan, et al.
Publicado: (2018)

Two different types of COVID-19 vaccines and serial liver biochemistries
por: Wong, Grace Lai-Hung, et al.
Publicado: (2022)

Hepatic Histological Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical Associations
por: Kleiner, David E, et al.
Publicado: (2014)

Noninvasive in vivo magnetic resonance measures of glutathione synthesis in human and rat liver as an oxidative stress biomarker
por: Skamarauskas, John T, et al.
Publicado: (2014)

Mesenchymal Stem Cells Alleviate Bacteria-Induced Liver Injury in Mice by Inducing Regulatory Dendritic Cells
por: Zhang, Yi, et al.
Publicado: (2014)

Sirtuin 2 aggravates postischemic liver injury by deacetylating mitogen‐activated protein kinase phosphatase‐1
por: Wang, Jie, et al.
Publicado: (2016)

Endogenous Histones Function as Alarmins in Sterile Inflammatory Liver Injury Through Toll-like Receptor 9 in Mice
por: Huang, Hai, et al.
Publicado: (2011)

Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital
por: Antoine, Daniel J, et al.
Publicado: (2013)

Circulating Kidney Injury Molecule 1 Predicts Prognosis and Poor Outcome in Patients With Acetaminophen‐Induced Liver Injury
por: Antoine, Daniel J., et al.
Publicado: (2015)

Incidence, phenotype and prognostic relevance of COVID-19-related liver injury across different age strata
por: Hartl, Lukas, et al.
Publicado: (2022)

Inhibition of RelA-Ser536 Phosphorylation by a Competing Peptide Reduces Mouse Liver Fibrosis Without Blocking the Innate Immune Response
por: Moles, Anna, et al.
Publicado: (2013)

A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug‐induced liver injury and postinjury inflammation in mice
por: Lundbäck, Peter, et al.
Publicado: (2016)

Three COVID-19 medications-remdesivir, molnupiravir and ritonavir-boosted nirmatrelvir-and serial liver biochemistries in 22, 456 subjects
por: Wong, Grace Lai-Hung, et al.
Publicado: (2022)

Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI)
por: Brennan, Paul N, et al.
Publicado: (2021)

Fulminant hepatitis
por: Sinclair, Stephen, et al.
Publicado: (1990)

Effects of Anesthesia on Ozone-Induced Lung and Systemic Inflammation
por: Wilson, Miranda L., et al.
Publicado: (2022)

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
por: Dyson, Jessica K, et al.
Publicado: (2014)

Global strategy for the diagnosis and management of acute kidney injury in patients with liver cirrhosis
por: Sanchez, Lukas Otero, et al.
Publicado: (2021)

Yes-Associated Protein Regulates the Hepatic Response After Bile Duct Ligation
por: Bai, Haibo, et al.
Publicado: (2012)

Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells
por: Dianat, Noushin, et al.
Publicado: (2014)

A novel phenotype‐based drug‐induced liver injury causality assessment tool (DILI‐CAT) allows for signal confirmation in early drug development
por: Hermann, Richard P., et al.
Publicado: (2022)

Description of Opioid-involved Hospital Deaths that Do Not Have a Subsequent Autopsy
por: Abasilim, Chibuzor, et al.
Publicado: (2022)

Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease
por: Martin, Anna, et al.
Publicado: (2022)

Current Approach to the Diagnosis and Treatment of Heterozygote and Homozygous FH Children and Adolescents
por: Cohen, Hofit, et al.
Publicado: (2021)

Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent
por: De Silva, Sampath, et al.
Publicado: (2018)

Network and satellite arrangements in liver disease
por: O'Grady, John G
Publicado: (2013)

Medical liver biopsy: background, indications, procedure and histopathology
por: Boyd, Alexander, et al.
Publicado: (2019)

Donor acquired visceral leishmaniasis following liver transplantation
por: Dhaliwal, Amritpal, et al.
Publicado: (2021)

Patient understanding of liver cirrhosis and improvement using multimedia education
por: Goldsworthy, Matthew A, et al.
Publicado: (2017)

PCSK9 Inhibitors in Real-world Practice: Analysis of Data from 314 Patients and 2 Years of Experience in a Center of Preventive Cardiology
por: Altschmiedová, Tereza, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease: a practical approach to treatment
por: Dyson, J K, et al.
Publicado: (2014)

Development and implementation of a commissioned pathway for the identification and stratification of liver disease in the community
por: Chalmers, Jane, et al.
Publicado: (2019)

Liver dysfunction in COVID-19: a useful prognostic marker of severe disease?
por: Lok, James, et al.
Publicado: (2020)

Adult liver transplantation: UK clinical guideline - part 2: surgery and post-operation
por: Millson, Charles, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7220jq2p8ja7n6a7u2fmaep04q